Covid19

FDA restricts J&J's COVID-19 vaccine due to blood clot risk – KOLD

U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious …

Read more at www.kold.com

Show More

Related Articles

Back to top button